Sort
23,748 grants matching “melanoma”
Augmenting Antitumor Immunity
$429,477Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2014 · CA
Project 3: Integrative Computational Analysis of Tumor-Mediated Immunosuppression
$429,462Sylvia Katina Plevritis · Stanford University · U54 · FY2017 · CA
Development of Salmonella vaccines for cancer and viruses
$429,260Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$429,256Edgar G. Engleman · Stanford University · U54 · FY2018 · CA
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$429,204Fan Pan · Johns Hopkins University · R01 · FY2018 · AI
Synergistic Targeting of the MAP Kinase Pathway in Melanoma
$429,201Ronen Marmorstein · Wistar Institute · P01 · FY2016 · CA
Developmental Funds
$429,179Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2015 · CA
Synergistic Targeting of the MAP Kinase Pathway in Melanoma
$429,145Ronen Marmorstein · Wistar Institute · P01 · FY2017 · CA
TCR-like antibodies for HPV-induced cancer basic research and theranostics
$429,120Roland K Strong · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves
$429,092Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2018 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$429,035Zhong-Yin Zhang · Purdue University · R01 · FY2021 · CA
The Metabolic Regulation of Melanoma Metastasis
$428,977Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2020 · CA
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
$428,973Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
$428,781Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA
Novel functions for NMDARs in neural crest development
$428,536Howard I Sirotkin · State University New York Stony Brook · R21 · FY2023 · HD
Targeting HSP70 for MelanomaTherapy
$428,529Maureen E Murphy · Wistar Institute · P01 · FY2020 · CA
Oncogenic Events in Thyroid Neoplasia
$428,500James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Oncogenic Events in Thyroid Neoplasia
$428,500James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
$428,455Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Identification of cancer neoepitope-specific T cells using novel high-throughput hydrogel based platforms
$428,438Jonathan P Schneck · Johns Hopkins University · R33 · FY2024 · CA
Tumor Stroma Interactions: Wound Promoted Tumor Growth
$428,364John Niederhuber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Project 2: Understanding the Cellular Origins of Melanoma
$428,337Anand K Ganesan · University Of California-Irvine · U54 · FY2022 · CA
CCR Confocal Microscopy Core
$428,299Langston Lim · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$428,162Chao Cheng · Baylor College Of Medicine · R01 · FY2024 · CA
Epigenetic and microenvironmental regulation of dormant disseminated cancer
$428,136Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA